The Schwab U.S. Dividend Equity ETF (SCHD) has emerged as a popular investment choice for those seeking a low-cost method to generate substantial yields from a diverse selection of dividend-paying stocks. Currently boasting $69 billion in net assets, the ETF features a remarkably low expense ratio of just 0.06%. This accessibility allows investors an attractive 30-day SEC yield of 3.7%, which significantly outpaces the 1.2% yield typically available from an S&P 500 index fund.
Despite its appeal, potential investors should note that SCHD is concentrated in a limited set of sectors, primarily focusing on energy, consumer staples, healthcare, and industrial fields. This concentration may present both advantages and challenges for those considering the ETF for their income portfolios.
The strategic allocation of the Dividend Equity ETF reflects a calculated approach to yield generation, heavily leaning towards traditional sectors known for their consistent dividend payouts. This means select companies focus on returning profits to shareholders, rather than reinvesting them for growth. Specifically, energy, consumer staples, and healthcare collectively account for 54% of the ETF’s investments, with energy making up a significant 19.2%—far exceeding the mere 3% allocation found in the S&P 500. Similarly, consumer staples are represented at 18.8%, contrasting sharply with their 5.2% representation in the larger index.
While some investors may express concern about the volatility often associated with the energy sector, SCHD counters this hesitation by investing in well-established companies known for their stability. Notably, Chevron (NYSE: CVX), which represents 4.4% of the ETF, is recognized for its robust balance sheet and a proven track record of increasing its dividend for 38 consecutive years. ConocoPhillips (NYSE: COP) and EOG Resources (NYSE: EOG) are other major holdings, further emphasizing the ETF’s focus on high-quality firms within the energy space.
In the consumer staples sector, the ETF features substantial stakes in industry leaders such as PepsiCo (NASDAQ: PEP) and Altria (NYSE: MO), both renowned for their long histories of dividend increases, with over 50 years of consistent payouts. These investments align well with the goal of generating reliable income for investors.
Healthcare is represented through significant positions in AbbVie (NYSE: ABBV) and Merck (NYSE: MRK), both titans in the pharmaceutical sector and known as Dividend Kings due to their strong dividend growth records. This focus on quality, rather than sheer growth, is critical for income-oriented investors.
For those looking to build passive income through equities, SCHD presents an appealing option. It provides a means for investors to earn significantly higher passive income compared to many value-focused funds, without heavily compromising on upside potential. While the 10-year Treasury rate hovers around 4.2%, the ETF’s yield comes with the promise of capital appreciation, as evidenced by its 129% capital gains over the past decade, resulting in a remarkable 217.4% total return when dividends are factored in.
Overall, the Schwab U.S. Dividend Equity ETF’s sector concentration is more of a strength than a drawback, making it a compelling choice for income investors who seek a straightforward way to invest in high-yield stocks. Its approach to dividend investing has positioned it as a valuable tool for those looking to enhance their income streams through strategic equity investments.
